An Evidence‑Based Framework for Molecular Test Selection in Oncology: Comparing Targeted NGS Panels and Comprehensive Sequencing
Kanako Okamoto 1$, Anthony Garcia 12$, James Cole 3, Sammy Kanugo 3, Jon Fretthold 3, Shuko Harada 1, Darshan Shimoga-Chandrashekar 1, A. Craig Mackinnon Jr. 11Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA2Current affiliation: Department of Pathology, University Hospital, Universidad Autónoma de Nuevo León (UANL), Monterrey, Nuevo León, Mexico3GenomOncology, Cleveland, OH, […]
GenomOncology Announces Integrated End-to-End Workflow Using PacBio’s Long-Read Whole-Genome Sequencing Technology in Oncology
Combined sample-to-report solution pairs PacBio HiFi WGS with GenomOncology Pathology Workbench to support clinical labs in delivering configurable, reimbursement-aligned genomic reports across tumor types CLEVELAND, July 30, 2026 (GLOBE NEWSWIRE) […]
GenomOncology’s EHR Integration: Automation from Order to Results
Introduction GenomOncology’s Pathology Workbench (GO PWB) is a tertiary analysis platform that performs annotation, interpretation, and clinical reporting for molecular laboratories offering NGS tests. Pathology Workbench offers extremely flexible integration […]
GenomOncology Announces Strategic Partnership with WeTrials to Accelerate Clinical Trial Enrollment for CNS Cancer Patients
CLEVELAND, March 10, 2026 /PRNewswire/ — GenomOncology, a leading precision medicine software company, today announced a strategic partnership with WeTrials, an AI-powered patient engagement and trial enablement platform, to help CNS cancer […]
GenomOncology Partners with OHSU Knight Diagnostics Lab to Accelerate Patient Access to Precision Oncology Clinical Trials
CLEVELAND, Jan. 14, 2026 /PRNewswire/ — GenomOncology (GO), a leader in precision medicine reporting solutions, today announced a strategic partnership with Oregon Health & Science University’s (OHSU) Knight Diagnostics Lab (KDL) to […]
GenomOncology Partners with Glioblastoma Foundation to Accelerate Precision Glioblastoma Brain Cancer Treatment
CLEVELAND and DURHAM, N.C., Nov. 11, 2025 /PRNewswire/ — GenomOncology today announced a strategic partnership with the Glioblastoma Foundation to transform genomic testing for the nation’s most aggressive brain cancer, glioblastoma. The […]
GenomOncology Announces BioMCP: Open Source Model Context Protocol (MCP) for Biomedical AI Assistants and Agents
CLEVELAND, April 10, 2025 /PRNewswire/ — GenomOncology today announced BioMCP, a new open-source technology that helps artificial intelligence (AI) systems access specialized medical information. BioMCP supports advanced searching and full-text retrieval from […]
GenomOncology Partners with Chronetyx Laboratories to Accelerate Cancer Care Through Comprehensive Genomic Profiling
CLEVELAND, March 31, 2025 /PRNewswire/ — GenomOncology, a precision medicine software company, today announced a strategic partnership with Chronetyx Laboratories, a leading provider of advanced diagnostic solutions, that will significantly reduce turnaround […]
Maximizing Clinical Utility to Inform Diagnosis of CNS Tumors
An insightful webinar exploring Belay Diagnostics’ groundbreaking liquid assay Summit and how it’s reshaping the diagnosis and treatment of brain and spinal cord tumors. Discover why this innovative technology offers […]
Belay Diagnostics Partners with GenomOncology to Support High-Performance Liquid Biopsy Test for Central Nervous System Cancer Detection
CLEVELAND, March 25, 2025 /PRNewswire/ — Belay Diagnostics announces its partnership with GenomOncology (GO), a precision medicine software company that provides data-driven tools and resources to improve cancer care. To streamline the tertiary analysis […]
